63 related articles for article (PubMed ID: 21726266)
21. Diagnosis and surgical treatment of multiple endocrine neoplasia.
Zhou GW; Wei Y; Chen X; Jiang XH; Li XY; Ning G; Li HW
Chin Med J (Engl); 2009 Jul; 122(13):1495-500. PubMed ID: 19719936
[TBL] [Abstract][Full Text] [Related]
22. Glucose homeostasis in Huntington disease: abnormalities in insulin sensitivity and early-phase insulin secretion.
Lalić NM; Marić J; Svetel M; Jotić A; Stefanova E; Lalić K; Dragasević N; Milicić T; Lukić L; Kostić VS
Arch Neurol; 2008 Apr; 65(4):476-80. PubMed ID: 18413469
[TBL] [Abstract][Full Text] [Related]
23. MEN1 gene mutations in Hungarian patients with multiple endocrine neoplasia type 1.
Balogh K; Hunyady L; Patocs A; Gergics P; Valkusz Z; Toth M; Racz K
Clin Endocrinol (Oxf); 2007 Nov; 67(5):727-34. PubMed ID: 17953629
[TBL] [Abstract][Full Text] [Related]
24. Regulation of vitamin D receptor function in MEN1-related parathyroid adenomas.
Dreijerink KM; Varier RA; van Nuland R; Broekhuizen R; Valk GD; van der Wal JE; Lips CJ; Kummer JA; Timmers HT
Mol Cell Endocrinol; 2009 Dec; 313(1-2):1-8. PubMed ID: 19729047
[TBL] [Abstract][Full Text] [Related]
25. Pituitary tumors and hyperplasia in multiple endocrine neoplasia type 1 syndrome (MEN1): a case-control study in a series of 77 patients versus 2509 non-MEN1 patients.
Trouillas J; Labat-Moleur F; Sturm N; Kujas M; Heymann MF; Figarella-Branger D; Patey M; Mazucca M; Decullier E; Vergès B; Chabre O; Calender A;
Am J Surg Pathol; 2008 Apr; 32(4):534-43. PubMed ID: 18300794
[TBL] [Abstract][Full Text] [Related]
26. Limitation of the validity of the homeostasis model assessment as an index of insulin resistance in Korea.
Kang ES; Yun YS; Park SW; Kim HJ; Ahn CW; Song YD; Cha BS; Lim SK; Kim KR; Lee HC
Metabolism; 2005 Feb; 54(2):206-11. PubMed ID: 15690315
[TBL] [Abstract][Full Text] [Related]
27. Multiple endocrine neoplasia type 1 (MEN1): its manifestations and effect of genetic screening on clinical outcome.
Pieterman CR; Schreinemakers JM; Koppeschaar HP; Vriens MR; Rinkes IH; Zonnenberg BA; van der Luijt RB; Valk GD
Clin Endocrinol (Oxf); 2009 Apr; 70(4):575-81. PubMed ID: 18616711
[TBL] [Abstract][Full Text] [Related]
28. Insulin resistance in men with treated hypertension at increased risk for cardiovascular disease: results of a 3-year study.
Mohteshamzadeh M; Wilkinson R; Thomas SH
Am J Hypertens; 2005 Apr; 18(4 Pt 1):452-6. PubMed ID: 15831352
[TBL] [Abstract][Full Text] [Related]
29. Are insulin resistance, impaired fasting glucose and impaired glucose tolerance all equally strongly related to age?
Qiao Q; Tuomilehto J; Balkau B; Borch-Johnsen K; Heine R; Wareham NJ;
Diabet Med; 2005 Nov; 22(11):1476-81. PubMed ID: 16241909
[TBL] [Abstract][Full Text] [Related]
30. Thyroid incidentalomas in patients with multiple endocrine neoplasia type 1.
Lodewijk L; Bongers PJ; Kist JW; Conemans EB; de Laat JM; Pieterman CR; van der Horst-Schrivers AN; Jorna C; Hermus AR; Dekkers OM; de Herder WW; Drent ML; Bisschop PH; Havekes B; Rinkes IH; Vriens MR; Valk GD
Eur J Endocrinol; 2015 Apr; 172(4):337-42. PubMed ID: 25572387
[TBL] [Abstract][Full Text] [Related]
31. Male Men1 heterozygous mice exhibit fasting hyperglycemia in the early stage of MEN1.
Gao Z; Zhang L; Xie W; Wang S; Bao X; Guo Y; Zhang H; Hu Q; Chen Y; Wang Z; Xue M; Jin G
J Endocrinol; 2016 Sep; 230(3):347-55. PubMed ID: 27432891
[TBL] [Abstract][Full Text] [Related]
32. Breast cancer risk in MEN1 - a cancer genetics perspective.
Brennan P
Clin Endocrinol (Oxf); 2015 Mar; 82(3):327-229. PubMed ID: 25279812
[TBL] [Abstract][Full Text] [Related]
33. Exploring the MEN1 dependent modulation of caspase 8 and caspase 3 in human pancreatic and murine embryo fibroblast cells.
Wagener N; Buchholz M; Bertolino P; Zhang CX; Di Fazio P
Apoptosis; 2022 Feb; 27(1-2):70-79. PubMed ID: 34878630
[TBL] [Abstract][Full Text] [Related]
34. De novo mutation in MEN1 is not associated with parental somatic mosaicism.
Laitman Y; Jaffe A; Schayek H; Friedman E
Endocr Relat Cancer; 2017 Jan; 24(1):L1-L3. PubMed ID: 27799361
[No Abstract] [Full Text] [Related]
35. Evaluation of MEN1 risk in individuals bearing R171Q. R171Q - single nucleotide polymorphism (SNP) or not SNP - that is the question.
Lampichler K; Ilhan A; Lang R; Daneva T; Wagner L; Knosp E; Niederle B; Baumgartner-Parzer SM
Clin Endocrinol (Oxf); 2011 Aug; 75(2):274. PubMed ID: 21521296
[No Abstract] [Full Text] [Related]
36. Neuroendocrinology: new model for MEN1 risk prediction.
Evans L
Nat Rev Endocrinol; 2012 Jun; 8(8):447. PubMed ID: 22664530
[No Abstract] [Full Text] [Related]
37. Pancreatic Neuroendocrine Tumors in MEN1 Patients: Difference in Post-Operative Complications and Tumor Progression between Major and Minimal Pancreatic Surgeries.
Tonelli F; Marini F; Giusti F; Iantomasi T; Giudici F; Brandi ML
Cancers (Basel); 2023 Oct; 15(20):. PubMed ID: 37894286
[TBL] [Abstract][Full Text] [Related]
38. Primary hyperparathyroidism in young patients is associated with metabolic disorders: a prospective comparative study.
Bibik EE; Dobreva EA; Elfimova AR; Miliutina AP; Eremkina AK; Gorbacheva AM; Krupinova JA; Koksharova EO; Sklyanik IA; Mayorov AY; Mokrysheva NG
BMC Endocr Disord; 2023 Mar; 23(1):57. PubMed ID: 36890506
[TBL] [Abstract][Full Text] [Related]
39. Phenotypes Associated With MEN1 Syndrome: A Focus on Genotype-Phenotype Correlations.
Mele C; Mencarelli M; Caputo M; Mai S; Pagano L; Aimaretti G; Scacchi M; Falchetti A; Marzullo P
Front Endocrinol (Lausanne); 2020; 11():591501. PubMed ID: 33312161
[TBL] [Abstract][Full Text] [Related]
40. Treatment of Pancreatic Neuroendocrine Tumors in Multiple Endocrine Neoplasia Type 1: Some Clarity But Continued Controversy.
Jensen RT; Norton JA
Pancreas; 2017; 46(5):589-594. PubMed ID: 28426491
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
